Closed-loop control of glucose according to a predicted blood glucose trajectory
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-005/172
A61B-005/145
A61B-005/00
G06F-019/00
A61M-005/142
출원번호
US-0103522
(2013-12-11)
등록번호
US-9750878
(2017-09-05)
발명자
/ 주소
Roy, Anirban
Keenan, Desmond Barry
Kovelman, Paul H.
출원인 / 주소
MEDTRONIC MINIMED, INC.
대리인 / 주소
Lorenz & Kopf, LLP
인용정보
피인용 횟수 :
1인용 특허 :
188
초록▼
Presented here are techniques for controlling glucose levels of a patient based on predicted time to a target glucose level. One methodology predicts a trajectory of the blood glucose level based on past observations of the blood glucose level, determines a cost expression based on the trajectory, a
Presented here are techniques for controlling glucose levels of a patient based on predicted time to a target glucose level. One methodology predicts a trajectory of the blood glucose level based on past observations of the blood glucose level, determines a cost expression based on the trajectory, and affects a future command to an infusion pump to affect a cost value according to the cost expression. Another methodology defines a target blood glucose concentration level for the patient, observes a current blood glucose concentration for the patient based on signals received from a blood-glucose sensor, and predicts a duration of time for the patient's blood glucose concentration to reach the target blood glucose concentration level based on the observed current blood glucose concentration.
대표청구항▼
1. A method comprising: predicting a trajectory of a blood glucose level of a patient based, at least in part, on past observations of said blood glucose level;determining a cost expression based, at least in part, on said predicted trajectory, wherein said cost expression is based, at least in part
1. A method comprising: predicting a trajectory of a blood glucose level of a patient based, at least in part, on past observations of said blood glucose level;determining a cost expression based, at least in part, on said predicted trajectory, wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under the lower bound blood glucose limit during said first duration of time, andwherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above the upper bound blood glucose limit during said second duration of time; andaffecting at least one future command to at least one infusion pump so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression. 2. The method of claim 1, wherein said at least one infusion pump comprises an insulin infusion pump. 3. The method of claim 1, wherein said at least one infusion pump comprises an infusion pump for glucagon. 4. The method of claim 1, wherein said cost expression is defined to cover a set duration in the future. 5. The method of claim 1, wherein said predicting, said determining the cost expression and said affecting said at least one future command is performed on command intervals. 6. An apparatus comprising: one or more infusion pumps to infuse a substance into a body in response to commands; anda controller to: predict a trajectory of a blood glucose level of said body based, at least in part, on past observations of said blood glucose level;determine a cost expression based, at least in part, on said predicted trajectory, wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, andwherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time; andaffect at least one future command to said one or more infusion pumps so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period wherein the at least one future command controls the system operation according to said cost expression. 7. The apparatus of claim 6, wherein said controller is further to generate said commands on discrete command intervals. 8. The apparatus of claim 6, wherein said one or more infusion pumps comprises an insulin infusion pump. 9. An article comprising: a non-transitory storage medium comprising machine-readable instructions executable by a special purpose computing apparatus to: predict a trajectory of a blood glucose level of the body based, at least in part, on past observations of said blood glucose level;determine a cost expression based, at least in part, on said predicted trajectory, wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, andwherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time; andaffect at least one future command to one or more infusion pumps so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression. 10. An apparatus comprising: a means for predicting a trajectory of a blood glucose level of a patient based, at least in part, on past observations of said blood glucose level;a means for determining a cost expression based, at least in part, on said predicted trajectory, wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, andwherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time; anda means for affecting at least one future command to at least one infusion pump to infuse a substance into the patient, and so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (188)
Batina, William P.; White, Robert M., Acquisition circuit for cardiac pacer.
Schulman Joseph H. ; Lucisano Joseph Y. ; Shah Rajiv ; Byers Charles L. ; Pendo Shaun M., Alumina insulation for coating implantable components and other microminiature devices.
Tune Joel (Antioch IL) Anderson Robert L. (Boulder CO) Blankenship Larry (Boulder CO) Colesworthy ; III Daniel C. (Boulder CO) Heim Warren P. (Boulder CO) Miller ; III Scott A. (Boulder CO) Sherman B, Ambulatory infusion pump.
Coutr James E. (Concord MA) Griffin Wayne P. (Dracut MA) Crisler Charles M. (Windham NH), An infusion management and pumping system having an alarm handling system.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S. ; Friedman Keith A. ; Colman Fredric C., Analyte monitoring device and methods of use.
Steil, Garry M.; Rebrin, Kerstin; Goode, Jr., Paul V.; Mastrototaro, John J.; Purvis, Richard E.; Van Antwerp, William P.; Shin, John J.; Talbot, Cary D., Closed loop system for controlling insulin infusion.
Prestele Karl (Erlangen DEX) Franetzki Manfred (Uttenreuth DEX) Reif Erich (Erlangen DEX), Device for the infusion of fluids into the human or animal body.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Electrochemical analyte.
James Say ; Michael F. Tomasco ; Adam Heller ; Yoram Gal IL; Behrad Aria ; Ephraim Heller ; Phillip John Plante ; Mark S. Vreeke, Electrochemical analyte sensor.
Gibson, Scott R.; Shah, Rajiv; Chernoff, Edward; Byers, Charles, Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat Zu Lubeck ; Klinik Fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat zu Lubeck ; Klinik fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Flex circuit connector.
Dempsey Michael K. (Acton MA) Kotfila Mark S. (Chelmsford MA) Snyder Robert J. (Westford MA), Flexible patient monitoring system featuring a multiport transmitter.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville R. (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Bever, Glucose monitoring system.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville Rey (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Beve, Glucose sensor assembly.
McIvor, K. Collin; Cabernoch, James L.; Branch, Kevin D.; Van Antwerp, Nannette M.; Halili, Edgardo C.; Mastrototaro, John J., Glucose sensor package system.
Allen Douglas J. (Indianapolis IN) Johnson Kirk W. (Indianapolis IN) Nevin Robert S. (Indianapolis IN), Hydrophilic polyurethane membranes for electrochemical glucose sensors.
Schulman Joseph H. ; Byers Charles L. ; Adomian Gerald E. ; Colvin Michael S., Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces.
Wilson George S. (Lawrence KS) Bindra Dilbir S. (Lawrence KS) Hill Brian S. (Lawrence KS) Thevenot Daniel R. (Paris Cedex FRX) Sternberg Robert (Thiais FRX) Reach Gerard (Paris Cedex KS FRX) Zhang Ya, Implantable glucose sensor.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Gargano Diane A. ; Flachbart Eric J. ; Cowen Barry ; Duh Monica ; Rudser ; Jr. John L. ; Zhen Ken ; Noble Lynn ; Warhurst Julian ; Pedraza Luis, Infusion pump for at least one syringe.
Coutre James E. (114 Stone Root La. Concord MA 01742) Griffin Wayne P. (55 Surrey La. Dracut MA 01826) Crisler Charles M. (10 Sunridge Rd. Windham NH 03087), Infusion pump management system for suggesting an adapted course of therapy.
Causey ; III James D. (Simi Valley CA) Schloss Harold C. (Los Angeles CA) Snell Jeffery D. (Northridge CA), Interactive programming and diagnostic system for use with implantable pacemaker.
Say, James L.; Sakslund, Henning; Tomasco, Michael F.; Audett, Jay D.; Cho, Hyun; Yamasaki, Duane O.; Heller, Adam, Mass transport limited in vivo analyte sensor.
Castellano Thomas P. (Beverly Hills CA) Schumacher Robert (Beverly Hills CA), Medication delivery device with a microprocessor and characteristic monitor.
Colman Fredric C. (Granada Hills CA) Purvis Richard E. (Glendale CA), Medication infusion system having optical motion sensor to detect drive mechanism malfunction.
Peterson Bruce A. (Milwaukie OR) Hogard Michael E. (Oregon City OR) Johnson Harley D. (Portland OR) Kelly Thomas D. (Portland OR) Long Jean M. (Portland OR) Preston ; Jr. William G. (Portland OR), Method and apparatus for kidney dialysis.
Joseph H. Schulman ; Joseph Y. Lucisano ; Rajiv Shah ; Charles L. Byers ; Shaun M. Pendo, Method of applying insulation for coating implantable components and other microminiature devices.
Feldman, Benjamin J.; Heller, Adam; Heller, Ephraim; Mao, Fei; Vivolo, Joseph A.; Funderburk, Jeffery V.; Colman, Fredric C.; Krishnan, Rajesh, Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator.
Moberg, Sheldon B.; Causey, III, James D.; Bare, Rex O.; Scherer, Andrew J.; Sargent, Bradley J., Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Brown Stephen J. ; Jensen Erik K., On-line health education and feedback system using motivational driver profile coding and automated content fulfillment.
Roizen Michael (Chicago IL) Turcotte ; II William E. (Oak Park IL) Pfisterer Richard E. (Arlington Heights IL), Portable medical interactive test selector having plug-in replaceable memory.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Process for producing an electrochemical biosensor.
Livingston John H. (Los Angeles CA) Frye Ward K. (San Luis Obispo CA) Field Jeffrey F. (Northridge CA), Proctective case for a medication infusion pump.
Sancoff Gregory E. (Leucadia CA) McWilliams Mark (San Diego CA) Barr Howard S. (Escondido CA) Cordner ; Jr. Edward T. (Carlsbad CA) Barton Russell C. (Monrovia CA), Programmable infusion system.
Shin, John J.; Holtzclaw, Kris R.; Dangui, Nandita D.; Kanderian, Jr., Sami; Mastrototaro, John J.; Hong, Peter I., Real time self-adjusting calibration algorithm.
Langen Pauline A. (Simsbury CT) Katz Jeffrey S. (West Hartford CT) Dempsey Gayle (Needham MA) Pompano James (East Haven CT), Remote monitoring of high-risk patients using artificial intelligence.
Epstein Paul (Brookline MA) Petschek Harry (Lexington MA) LaWhite Eric (South Royalton VT) Strohl Clair (Norfolk MA) Coyne Henry (Framington MA) Kaleskas Edward (Jefferson MA) Adaniya George (Swampsc, Remotely programmable infusion system.
Lundquist Ingemar H. (Pebble Beach CA) Tarczy-Hornoch Zoltan (Berkeley CA) Kardos Thomas J. (Laguna Beach CA), Retroperfusion and retroinfusion control apparatus, system and method.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Nason Clyde K. (25745 N. Player Dr. Valencia CA 91355) Culp Gordon W. (13832 Haynes St. Van Nuys CA 91401), Solenoid drive apparatus for an external infusion pump.
Aoki Thomas T. (1021 El Sur Way Sacramento CA 95825), System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof.
Tacklind Christopher A. (Palo Alto CA) Sanders Matthew H. (Los Altos Hills CA) Walne Geoffrey B. (Atherton CA), System for monitoring and reporting medical measurements.
Blomquist Michael L. (Coon Rapids MN) Peterson Thomas L. (Shoreview MN), Systems and methods for operating ambulatory medical devices such as drug delivery devices.
Mann, Alfred E.; Purvis, Richard E.; Mastrototaro, John J.; Causey, James D.; Henke, James; Hong, Peter; Livingston, John H.; Hague, Clifford W.; Hite, Brad T., Telemetered characteristic monitor system and method of using the same.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Transcutaneous sensor insertion set.
Gerety, Eugene P.; Strempski, Richard A.; Sardi, Stephen G., Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same.
Carter,Scott J.; Flanders,Edward L.; Hannah,Stephen E., Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.